Merck Sharp & Dohme B.V.

Waarderweg 39,
Haarlem, 2031
Netherlands,
+31 23 515 3153
www.msd.nl

Merck Sharp & Dohme B.V., a wholly owned subsidiary of Merck & Co., Inc. (NYSE:MRK). Merck Sharp & Dohme B.V provides medicines for diabetes, High blood pres pressure and rheumatic disease patients.

M&A Summary

Buy vs Sell

Year ≤ '12 '13 '14 '15 '16 '17 T
Buy (0.0/yr) # 2 - - - - - 2
Sell (0.6/yr) # - 2 - 1 - - 3
vol $240M $240M
  5

Top M&A Advisors

Financial Deals
Join to Access.
Legal Deals
Join to Access.

Deal Values

Buy # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View
Largest Saphris
$240M (2013-12-02)

According to our data here at Mergr, Merck Sharp & Dohme B.V. has acquired 2 companies. It has also divested 3 assets.

It’s largest disclosed sale occurred in 2013, when it sold Saphris to Forest Laboratories Holdings for $240M. Merck Sharp & Dohme B.V. has acquired in 1 US state. The Company’s most targeted sectors include information technology (50%) and life science (50%).

When analyzing the medical products sector as a whole, according to Mergr, in the last 3 years, there are 332 medical products companies that have made at least 1 acquisition, 17 have acquired at least 5 companies, and 4 have acquired more than 10 companies. The most prolific strategic medical products acquirer over the past 3 years is Medtronic, with 12 acquisitions. The most prolific private equity acquirer in the medical products sector over the past 3 years is SHS GmbH with 7 platform acquisitions.

Join Mergr and gain access to Merck Sharp & Dohme B.V.’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the medical products sector.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.1K Private Equity Firms
  • 110K M&A Transactions
  • 120K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.